• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】68139

【品名】methyl 2-aminopyrimidine-5-carboxylate

【CA登记号】308348-93-8

【 分 子 式 】C6H7N3O2

【 分 子 量 】153.1406

【元素组成】C 47.06% H 4.61% N 27.44% O 20.9%

与该中间体有关的原料药合成路线共 1 条

合成路线1

该中间体在本合成路线中的序号:(XVII)

Nitration of vanillin acetate (I) by means of HNO3 yields the 2-nitrobenzaldehyde derivative (II), which by hydrolysis of the acetate ester with K2CO3 in MeOH provides 2-nitrovanillin (III). Protection of phenol (III) by means of benzyl bromide and K2CO3 in DMF gives the corresponding benzyl ether (IV), which by reaction of the aldehyde moiety with iodine and excess NH3 in H2O/THF results in nitrile (V). Reduction of the nitro group in compound (V) using Fe and AcOH, followed by cyclization of the resulting aminonitrile (VI) with ethylenediamine (VII) in the presence of sulfur affords imidazoline (VIII). Subsequent ring closure of the aminoimidazoline derivative (VIII) with cyanogen bromide (IX) by means of Et3N in CH2Cl2 yields the imidazo[1,2-c] quinazoline derivative (X), which is then debenzylated by means of TFA to give the corresponding phenol (XI). Alkylation of phenol (XI) with 4-(3-chloropropyl)morpholine (XII) in the presence of Cs2CO3 in DMF affords the morpholinopropyl ether (XIII) (1), which is finally condensed with 2-aminopyrimidine-5-carboxylic acid (XIV) using PyBOP and DIEA in DMF .
2-Aminopyrimidine-5-carboxylic acid (XIV) is prepared by cyclization of sodium 2-(dimethoxymethyl)-3-methoxy-3-oxoprop-1(Z)-en-1-olate (XV) with guanidine hydrochloride (XVI) to provide methyl 2-aminopyrimidine-5-carboxylate (XVII), which is then hydrolyzed with LiOH in MeOH .

1 Scott, W.J., Hentemann, S.M., Rowley, B. et al. Novel 2,3-dihydroimidazo[1,2-c]quinazolines PI3K inhibitors: Discovery and SAR. 22nd EORTCNCI-AACR Symp Mol Targets Cancer Ther (Nov 16-19, Berlin) 2010, Abst 444.
2 Hentemann, M., Wood, J., Scott, W. et al. (Bayer Pharmaceuticals Corp.). Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis. EP 2096919, JP 2010511718, US 2011083984, US 8466283, US 201326113, WO 2008070150.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 68135 5-amino-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-8-ol bis(2,2,2-trifluoroacetate)   C11H12N4O2.2C2HF3O2 详情 详情
(I) 68127 vanillin acetate;4-Acetoxy-3-methoxybenzaldehyde;4-Formyl-2-methoxyphenyl acetate 881-68-5 C10H10O4 详情 详情
(II) 68128 4-formyl-2-methoxy-3-nitrophenyl acetate;4-O-Acetyl-2-nitrovanillin;4-(acetyloxy)-3-methoxy-2-nitro-Benzaldehyde 2698-69-3 C10H9NO6 详情 详情
(III) 68129 2-nitrovanillin;4-Hydroxy-3-methoxy-2-nitrobenzaldehyde   C8H7NO5 详情 详情
(IV) 68130 4-(benzyloxy)-3-methoxy-2-nitrobenzaldehyde   C15H13NO5 详情 详情
(V) 68131 4-(benzyloxy)-3-methoxy-2-nitrobenzonitrile   C15H12N2O4 详情 详情
(VI) 68132 2-amino-4-(benzyloxy)-3-methoxybenzonitrile   C15H14N2O2 详情 详情
(VII) 14754 ethylenediamine;1,2-Diaminoethane;ethane-1,2-diamine;1,2-Ethanediamine 107-15-3 C2H8N2 详情 详情
(VIII) 68133 3-(benzyloxy)-6-(4,5-dihydro-1H-imidazol-2-yl)-2-methoxyaniline   C17H19N3O2 详情 详情
(IX) 28017 cyanic bromide;cyanogen bromide 506-68-3 CBrN 详情 详情
(X) 68134 8-(benzyloxy)-7-methoxy-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine   C18H18N4O2 详情 详情
(XIII) 68137 7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-amine   C18H25N5O3 详情 详情
(XIV) 68136 2-aminopyrimidine-5-carboxylic acid;2-Amino-5-carboxypyrimidine;2-Amino-5-pyrimidinecarboxylic acid 3167-50-8 C5H5N3O2 详情 详情
(XV) 68138 sodium (Z)-2-(dimethoxymethyl)-3-methoxy-3-oxoprop-1-en-1-olate   C7H11NaO5 详情 详情
(XVI) 14262 Guanidine hydrochloride 50-01-1 CH5N3.HCl 详情 详情
(XVII) 68139 methyl 2-aminopyrimidine-5-carboxylate 308348-93-8 C6H7N3O2 详情 详情
Extended Information